Jones James bought CPIX
October 20, 2025 · Form 4 insider transaction
Jones James bought 13 shares of Cumberland Pharmaceuticals Inc. at $3.52 per share, a transaction worth $45.76. The trade was recorded as l under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 14 days after the transaction.
Direction
Acquired (buy-side)
Shares
13
Price
$3.52
Total value
$45.76
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeL: L
Transaction dateOctober 20, 2025
Filing dateNovember 3, 2025
Shares owned after44,374
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.